Bifidobacterium longum 1714
Bifidobacterium longum 1714 is among the strains studied under the term "psychobiotic," used for gut bacteria examined for potential effects via the gut-brain axis. Multiple randomized controlled trials in healthy adults have examined this strain in relation to stress-related electrophysiology, social cognition, sleep quality, well-being, and mood, including a 2026 placebo-controlled trial. In vitro work has examined exopolysaccharides and tryptophan metabolism in relation to immune signaling, though the mechanisms relevant to humans remain under investigation. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 16 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 12 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
20 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
Source →The Combination of Anxiety and Depressive Disorders in Patients with Irritable Bowel Syndrome (Literature Review and Expert Council Resolution)· Russian Journal of Gastroenterology Hepatology Coloproctology · 2026
-
[2]
PMID 41140527 →Complementary immunoregulatory effects of Bifidobacterium longum 1714TM associated exopolysaccharide and tryptophan metabolism· Current Research in Microbial Sciences · 2025
-
[3]
PMID 38355674 →Bifidobacterium longum 1714 improves sleep quality and aspects of well-being in healthy adults: a randomized, double-blind, placebo-controlled clinical trial· Scientific Reports · 2024
-
[4]
PMID 30998517 →Bifidobacterium longum 1714™ Strain Modulates Brain Activity of Healthy Volunteers During Social Stress· The American Journal of Gastroenterology · 2019
-
[5]
PMID 31268916 →Psychobiotics: Shaping the Mind With Gut Bacteria· The American Journal of Gastroenterology · 2019
-
[6]
PMID 27801892 →Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers· Translational Psychiatry · 2016